SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
|
Bark, Inc. (Name of Issuer) |
Common Stock (Title of Class of Securities) |
68622E104 (CUSIP Number) |
Carly Strife 120 Broadway, Floor 12, New York, NY, 10271 855-501-2275 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
12/19/2024 (Date of Event Which Requires Filing of This Statement) |
SCHEDULE 13D
|
CUSIP No. | 68622E104 |
1 |
Name of reporting person
Carly Strife | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
PF | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
6 | Citizenship or place of organization
UNITED STATES
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
8,571,240.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
13 | Percent of class represented by amount in Row (11)
4.9 % | ||||||||
14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
Item 1. | Security and Issuer |
(a) | Title of Class of Securities:
Common Stock |
(b) | Name of Issuer:
Bark, Inc. |
(c) | Address of Issuer's Principal Executive Offices:
120 Broadway, Floor 12, New York,
NEW YORK
, 10271. |
Item 2. | Identity and Background |
(a) | Carly Strife |
(b) | The business address of the Reporting Person is c/o Bark, Inc., 120 Broadway, Floor 12, New York, NY 10271. |
(c) | The Reporting Person is an entrepreneur. |
(d) | During the past five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). |
(e) | The Reporting Person is not, nor during the last five years has been, a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |
(f) | The Reporting Person is a citizen of the United States. |
Item 3. | Source and Amount of Funds or Other Consideration |
Item 3 of the Original Schedule 13D is hereby amended and supplemented to add the following language:
On December 16, 2024, the Reporting Person sold 100,000 shares of Common Stock at a weighted-average sales price of $2.1532 per share for aggregate sale proceeds of $215,320.00.
On December 17, 2024, the Reporting Person sold 100,000 shares of Common Stock at a weighted-average sales price of $2.1850 per share for aggregate sale proceeds of $218,500.00.
On December 18, 2024, the Reporting Person sold 66,340 shares of Common Stock at a weighted-average sales price of $2.0630 per share for aggregate sale proceeds of $136,959.42.
On December 19, 2024, the Reporting Person sold 16,854 shares of Common Stock at a weighted-average sales price of $2.0127 per share for aggregate sale proceeds of $33,922.05. | |
Item 4. | Purpose of Transaction |
Except as described herein, neither the Reporting Person nor any affiliated trusts or entities has any present plans or proposals that relate to or would result in any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. However, the Reporting Person and the Trust reserve the right to formulate in the future plans or proposals which may relate to or result in the transactions described in subparagraphs (a) through (j) of this Item 4.
The Reporting Person and the Trust holds the securities of the Issuer for general investment purposes. The Reporting Person and the Trust reserves the right, based on all relevant factors and subject to applicable law or other restrictions, at any time and from time to time, to acquire additional shares of Common Stock or other securities of the Issuer, dispose of some or all of the shares of Common Stock or other securities of the Issuer that it may own from time to time, in each case in open market or private transactions, block sales or otherwise or pursuant to ordinary stock exchange transactions effected through one or more broker-dealers whether individually or utilizing specific pricing or other instructions (including by means of Rule 10b5-1 programs). | |
Item 5. | Interest in Securities of the Issuer |
(a) | See Items 7-11 and 13 of the cover pages of this Statement for each Reporting Person and Item 2 above. |
(b) | See Items 7-11 and 13 of the cover pages of this Statement for each Reporting Person and Item 2 above. |
(c) | Except as reported in this Statement, the Reporting Person has not effected any transactions in the Issuer's securities within the past 60 days. |
(d) | Except as reported in this Statement, no other person is known to the Reporting Person to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock covered by this Statement. |
(e) | On December 19, 2024, the Reporting Person ceased to be the beneficial owner of more than five percent of the outstanding shares of Common Stock. |
Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
The information set forth in Item 3 of this Statement is incorporated into this Item 6 by reference. | |
Item 7. | Material to be Filed as Exhibits. |
Not applicable |
SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|